Kazuhiro Takahashi

Dr. Kazuhiro Takahashi


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in International Surgery
Verified
Journal Article
Closed access
KTKazuhiro Takahashi
Kazuhiro Takahashi
HTHideo Terashima
Hideo Terashima
KKKeisuke Kohno
Keisuke Kohno
NONobuhiro Ohkohchi
Nobuhiro Ohkohchi
Synbiotics are combinations of probiotics and prebiotics that have recently been used in the context of various gastrointestinal diseases, including infectious enteritis, inflammatory bowel disease, and bowel obstruction. We encountered a patient with recurrent D-lactic acidosis who was treated successfully for long periods using synbiotics. The patient was diagnosed as having short bowel syndrome and had recurrent episodes of neurologic dysfunction due to D-lactic acidosis. In addition to fasting, the patient had been treated with antibiotics to eliminate D-lactate–producing bacteria. After the failure of antibiotic treatment, a stand-alone synbiotic treatment was started, specifically Bifidobacterium breve Yakult and Lactobacillus casei Shirota as probiotics, and galacto-oligosaccharide as a prebiotic. Serum D-lactate levels declined, and the patient has been recurrence-free for 3 years without dietary restriction. Synbiotics allowed the reduction in colonic absorption of D-lactate by both prevention of D-lactate–producing bacterial overgrowth and stimulation of intestinal motility, leading to remission of D-lactate acidosis.

Verified
Journal Article
Open access
PDF file
SMSoichiro Murata
Soichiro Murata
TMTakehito Maruyama
Takehito Maruyama
TNTakeshi Nowatari
Takeshi Nowatari
KTKazuhiro Takahashi
Kazuhiro Takahashi
NONobuhiro Ohkohchi
Nobuhiro Ohkohchi
Platelets contain three types of granules: alpha granules, dense granules, and lysosomal granules. Each granule contains various growth factors, cytokines, and other physiological substances. Platelets trigger many kinds of biological responses, such as hemostasis, wound healing, and tissue regeneration. This review presents experimental evidence of platelets in accelerating liver regeneration and improving liver fibrosis. The regenerative effect of liver by platelets consists of three mechanisms; i.e., the direct effect on hepatocytes, the cooperative effect with liver sinusoidal endothelial cells, and the collaborative effect with Kupffer cells. Many signal transduction pathways are involved in hepatocyte proliferation. One is activation of Akt and extracellular signal-regulated kinase (ERK)1/2, which are derived from direct stimulation from growth factors in platelets. The other is signal transducer and activator of transcription-3 (STAT3) activation by interleukin (IL)-6 derived from liver sinusoidal endothelial cells and Kupffer cells, which are stimulated by contact with platelets during liver regeneration. Platelets also improve liver fibrosis in rodent models by inactivating hepatic stellate cells to decrease collagen production. The level of intracellular cyclic adenosine monophosphate (cyclic AMP) is increased by adenosine through its receptors on hepatic stellate cells, resulting in inactivation of these cells. Adenosine is produced by the degradation of adenine nucleotides such as adenosine diphosphate (ADP) and adenosine tri-phosphate (ATP), which are stored in abundance within the dense granules of platelets.

23 May 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
KTKazuhiro Takahashi
Kazuhiro Takahashi
SJSyed‐Mohammed R. Jafri
Syed‐Mohammed R. Jafri
MSMohamed Safwan
Mohamed Safwan
MAMarwan S. Abouljoud
Marwan S. Abouljoud
SNShunji Nagai
Shunji Nagai

27 March 2021 in World Journal of Hepatology
Verified
Journal Article
Open access
KTKazuhiro Takahashi
Kazuhiro Takahashi
JKJaejeong Kim
Jaejeong Kim
ATAmane Takahashi
Amane Takahashi
SHShinji Hashimoto
Shinji Hashimoto
MDManami Doi
Manami Doi
TOTatsuya Oda
Tatsuya Oda
Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report

4 December 2020 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
CLChen Liang
Chen Liang
KTKazuhiro Takahashi
Kazuhiro Takahashi
KFKinji Furuya
Kinji Furuya
TOTatsuya Oda
Tatsuya Oda
NONobuhiro Ohkohchi
Nobuhiro Ohkohchi

1 January 2013 in International Surgery
Verified
Journal Article
Closed access
KTKazuhiro Takahashi
Kazuhiro Takahashi
RSRyoko Sasaki
Ryoko Sasaki
YOYukio Oshiro
Yukio Oshiro
KFKiyoshi Fukunaga
Kiyoshi Fukunaga
TOTatsuya Oda
Tatsuya Oda
NONobuhiro Ohkohchi
Nobuhiro Ohkohchi
We encountered a rare case of a well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst (CCC). The patient is a 28-year-old woman referred to our clinic for pruritus. Laboratory data showed mild elevation of serum hepatobiliary enzymes. Computed tomography and magnetic resonance imaging demonstrated pancreatobiliary maljunction and a Todani type IV-A CCC from the inferior bile duct to the bilateral intrahepatic bile ducts. A solid tumor was detected in the middle portion of the common bile duct. Pancreatoduodenectomy and total extrahepatic bile duct resection was performed. Based on pathologic and immunohistochemical examinations, a diagnosis of well-differentiated endocrine carcinoma was made according to the World Health Organization criteria. To our knowledge, this is the third report of a neuroendocrine tumor originating from the bile duct in association with a CCC.